Warm Autoimmune Hemolytic Anemia Market Projected to Expand with Advanced Therapies
Warm Autoimmune Hemolytic Anemia (WAIHA) is characterized by destruction of red blood cells due to autoantibodies targeting erythrocyte membranes at normal body temperature. Therapeutic options include corticosteroids, immunosuppressants, monoclonal antibodies, and emerging targeted biologics that work by modulating B-cell activity or complement pathways. Advanced treatments such as rituximab...
0 Comments 0 Shares 93 Views 0 Reviews